139 related articles for article (PubMed ID: 1664469)
1. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T
Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
3. [Aminoglycosides resistance of methicillin-resistant Staphylococcus aureus].
Okamoto R; Okubo T
Nihon Rinsho; 1992 May; 50(5):1036-41. PubMed ID: 1324330
[TBL] [Abstract][Full Text] [Related]
4. [The enzymatic mechanisms of resistance to aminoglycoside antibiotics in methicillin-cephem-resistant Staphylococcus aureus].
Matsuhashi Y; Yamamoto H
Jpn J Antibiot; 1988 May; 41(5):523-9. PubMed ID: 3216474
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. II. Isolation of arbekacin-resistant strain.
Inouye Y; Morifuji K; Masumi N; Nakamura S; Takesue Y; Santou T; Yokoyama T
Hiroshima J Med Sci; 1992 Dec; 41(4):79-85. PubMed ID: 1293073
[TBL] [Abstract][Full Text] [Related]
7. [A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
Wang R; Nishioka K; Tanno Y
Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):95-8. PubMed ID: 8070299
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
Uete T; Matsuo K; Uete G
Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus].
Watanabe T; Goi H; Hara T; Sugano T; Tanaka Y; Kazuno Y; Matsuhashi Y; Yamamoto H; Yokota T
Jpn J Antibiot; 1987 Feb; 40(2):349-56. PubMed ID: 3648153
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of MICs on 16 antimicrobial agents for freshly isolated methicillin-resistant Staphylococcus aureus strains].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y
Jpn J Antibiot; 1990 Apr; 43(4):623-35. PubMed ID: 2381034
[TBL] [Abstract][Full Text] [Related]
11. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902
[TBL] [Abstract][Full Text] [Related]
12. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
[TBL] [Abstract][Full Text] [Related]
13. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activities of various aminoglycosides against clinically isolated methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K; Kato M
Jpn J Antibiot; 1987 Nov; 40(11):1941-5. PubMed ID: 3444031
[TBL] [Abstract][Full Text] [Related]
15. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
[TBL] [Abstract][Full Text] [Related]
16. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683
[TBL] [Abstract][Full Text] [Related]
17. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
Watanabe T; Kanno M; Sobu K; Takase Y; Yoshida T
Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
Felmingham D; Jones K
Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
[TBL] [Abstract][Full Text] [Related]
19. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents.
Sowa S; Masumi N; Inouye Y; Nakamura S; Takesue Y; Yokoyama T
Hiroshima J Med Sci; 1991 Dec; 40(4):137-44. PubMed ID: 1797744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
